SEC filing record
Primary Source · SEC.gov

Microbot Medical Inc.

2025 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2025-09-30Last filing 2025-09-30

Raised

$25M

Investors

1

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Microbot Medical Inc. is a Delaware corporation that filed a Form D with the SEC on September 30, 2025 in the Biotechnology industry group. The offering claims Rule 506(b). Microbot Medical Inc. reported $25,244,903 sold from 1 investor of a $25,244,903 total offering as of the Form D filed September 30, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names H.C. WAINWRIGHT & CO., LLC (CRD 000000375), associated with None as the recipient of sales compensation soliciting in NY. Sales commissions are reported as $2,095,542 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 25 Recreation Park Dr Suite 108, Hingham, MA 02043.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0000883975
Entity NameMicrobot Medical Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address25 Recreation Park Dr Suite 108, Hingham, MA 02043
Phone(908) 938-5561
Former NamesMicrobot Medical Inc. (until November 16, 2026); STEMCELLS INC (until November 15, 2016); CYTOTHERAPEUTICS INC/DE (until May 15, 2000)
Industry / Fund TypeBiotechnology
Securities Type—
First Sale DateSeptember 16, 2025
Filing DateSeptember 30, 2025
Accession Number0001493152-25-016081
Total Offering Amount$25,244,903
Total Amount Sold$25,244,903
Amount Remaining$0
Amount Sold NoteCombined figure across related vehicles: The Total Offering Amount reflects the aggregate exercise price of the inducement preferred investment options and the exercise price of the placement agent preferred investment options.
Total Investors1
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$2,095,542 (to H.C. WAINWRIGHT & CO., LLC)
Finders' Fees$0
Revenue RangeDecline to Disclose
State (Issuer Address)MA
Amendment Count10 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest Sep 30, 2025

Critical / warning

0 / 0

1 watch · 4 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

10

closed, lapsed

Latest event New filer · Sep 30, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2025-09-30, and alerts on the next one
  • 10 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

HAREL GADOT

Executive Officer, Director · BRAINTREE, MA

SIMON SHARON

Executive Officer · BRAINTREE, MA

Juan Diaz- Cartelle

Executive Officer · BRAINTREE, MA

Rachel Vaknin

Executive Officer · BRAINTREE, MA

Martin Madden

Director · BRAINTREE, MA

Scott Burell

Director · BRAINTREE, MA

Aileen Stockburger

Director · BRAINTREE, MA

David Wilson

Director · BRAINTREE, MA

Prattipati Laxminarain

Director · BRAINTREE, MA

Tal Wenderow

Director · BRAINTREE, MA

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

H.C. WAINWRIGHT & CO., LLCCRD 000000375 on BrokerCheck

Associated broker-dealer: None · NEW YORK, NY · Soliciting in NY

Questions About Microbot Medical Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Microbot Medical Inc.?

Microbot Medical Inc. is a Delaware corporation that filed a Form D with the SEC on September 30, 2025 in the Biotechnology industry group. The filing claims Rule 506(b).

Is Microbot Medical Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Microbot Medical Inc. filed a Form D with the SEC on September 30, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $25,244,903 sold to 1 investor. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Microbot Medical Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Microbot Medical Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Microbot Medical Inc. raised?

Microbot Medical Inc. reported $25,244,903 sold from 1 investor of a $25,244,903 total offering as of the Form D filed September 30, 2025. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in Microbot Medical Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Microbot Medical Inc.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Microbot Medical Inc. and how are they paid?

The Form D names H.C. WAINWRIGHT & CO., LLC (CRD 000000375), associated with None as the recipient of sales compensation soliciting in NY. Sales commissions are reported as $2,095,542 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Microbot Medical Inc.?

The Form D lists 10 related persons: HAREL GADOT, executive officer, director; SIMON SHARON, executive officer; Juan Diaz- Cartelle, executive officer; Rachel Vaknin, executive officer; Martin Madden, director; Scott Burell, director; Aileen Stockburger, director; David Wilson, director, and 2 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Microbot Medical Inc. located?

The issuer's address on its SEC filings is 25 Recreation Park Dr Suite 108, Hingham, MA 02043. Its phone number of record is 908-938-5561. It is organized under the laws of Delaware.

How long is the Microbot Medical Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Microbot Medical Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.